Sartorius Cell Therapy Product Characterization Services

Cell therapy products like mesenchymal stem cells and cellular immunotherapies such as Chimeric Antigen Receptor T cells (CAR-T) face the regulatory challenge of meeting rigorous standards for safety and characterization. In autologous therapy programs, the timeline between product manufacture and release is short and rapid testing solutions are required.

Sartorius Stedim North America cell therapy product characterization services combine rapid PCR, ELISA and custom methods tailored to these product types from a single contract partner with fully compliant cGMP facilities and options for research grade testing available.